Table of Content

1 Personalized Cell Therapeutic Market Overview
1.1 Product Overview and Scope of Personalized Cell Therapeutic
1.2 Personalized Cell Therapeutic Segment by Type
1.2.1 Global Personalized Cell Therapeutic Market Value Comparison by Type (2023-2033)
1.2.2 Embryonic Stem Cells
1.2.3 Adult Stem Cell
1.2.4 Induced Pluripotent Cells
1.2.5 Other
1.3 Personalized Cell Therapeutic Segment by Application
1.3.1 Global Personalized Cell Therapeutic Market Value by Application: (2023-2033)
1.3.2 Cardiovascular Diseases
1.3.3 Neurological Disorders
1.3.4 Diabetes
1.3.5 Oncology
1.3.6 Other
1.4 Global Personalized Cell Therapeutic Market Size Estimates and Forecasts
1.4.1 Global Personalized Cell Therapeutic Revenue 2018-2033
1.4.2 Global Personalized Cell Therapeutic Sales 2018-2033
1.4.3 Global Personalized Cell Therapeutic Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Personalized Cell Therapeutic Market Competition by Manufacturers
2.1 Global Personalized Cell Therapeutic Sales Market Share by Manufacturers (2018-2023)
2.2 Global Personalized Cell Therapeutic Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Personalized Cell Therapeutic Average Price by Manufacturers (2018-2023)
2.4 Global Personalized Cell Therapeutic Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Personalized Cell Therapeutic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Personalized Cell Therapeutic, Product Type & Application
2.7 Personalized Cell Therapeutic Market Competitive Situation and Trends
2.7.1 Personalized Cell Therapeutic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Personalized Cell Therapeutic Players Market Share by Revenue
2.7.3 Global Personalized Cell Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Personalized Cell Therapeutic Retrospective Market Scenario by Region
3.1 Global Personalized Cell Therapeutic Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Personalized Cell Therapeutic Global Personalized Cell Therapeutic Sales by Region: 2018-2033
3.2.1 Global Personalized Cell Therapeutic Sales by Region: 2018-2023
3.2.2 Global Personalized Cell Therapeutic Sales by Region: 2024-2033
3.3 Global Personalized Cell Therapeutic Global Personalized Cell Therapeutic Revenue by Region: 2018-2033
3.3.1 Global Personalized Cell Therapeutic Revenue by Region: 2018-2023
3.3.2 Global Personalized Cell Therapeutic Revenue by Region: 2024-2033
3.4 North America Personalized Cell Therapeutic Market Facts & Figures by Country
3.4.1 North America Personalized Cell Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Personalized Cell Therapeutic Sales by Country (2018-2033)
3.4.3 North America Personalized Cell Therapeutic Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe Personalized Cell Therapeutic Market Facts & Figures by Country
3.5.1 Europe Personalized Cell Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Personalized Cell Therapeutic Sales by Country (2018-2033)
3.5.3 Europe Personalized Cell Therapeutic Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Personalized Cell Therapeutic Market Facts & Figures by Country
3.6.1 Asia Pacific Personalized Cell Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Personalized Cell Therapeutic Sales by Country (2018-2033)
3.6.3 Asia Pacific Personalized Cell Therapeutic Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Personalized Cell Therapeutic Market Facts & Figures by Country
3.7.1 Latin America Personalized Cell Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Personalized Cell Therapeutic Sales by Country (2018-2033)
3.7.3 Latin America Personalized Cell Therapeutic Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Personalized Cell Therapeutic Market Facts & Figures by Country
3.8.1 Middle East and Africa Personalized Cell Therapeutic Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Personalized Cell Therapeutic Sales by Country (2018-2033)
3.8.3 Middle East and Africa Personalized Cell Therapeutic Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Personalized Cell Therapeutic Sales by Type (2018-2033)
4.1.1 Global Personalized Cell Therapeutic Sales by Type (2018-2023)
4.1.2 Global Personalized Cell Therapeutic Sales by Type (2024-2033)
4.1.3 Global Personalized Cell Therapeutic Sales Market Share by Type (2018-2033)
4.2 Global Personalized Cell Therapeutic Revenue by Type (2018-2033)
4.2.1 Global Personalized Cell Therapeutic Revenue by Type (2018-2023)
4.2.2 Global Personalized Cell Therapeutic Revenue by Type (2024-2033)
4.2.3 Global Personalized Cell Therapeutic Revenue Market Share by Type (2018-2033)
4.3 Global Personalized Cell Therapeutic Price by Type (2018-2033)
5 Segment by Application
5.1 Global Personalized Cell Therapeutic Sales by Application (2018-2033)
5.1.1 Global Personalized Cell Therapeutic Sales by Application (2018-2023)
5.1.2 Global Personalized Cell Therapeutic Sales by Application (2024-2033)
5.1.3 Global Personalized Cell Therapeutic Sales Market Share by Application (2018-2033)
5.2 Global Personalized Cell Therapeutic Revenue by Application (2018-2033)
5.2.1 Global Personalized Cell Therapeutic Revenue by Application (2018-2023)
5.2.2 Global Personalized Cell Therapeutic Revenue by Application (2024-2033)
5.2.3 Global Personalized Cell Therapeutic Revenue Market Share by Application (2018-2033)
5.3 Global Personalized Cell Therapeutic Price by Application (2018-2033)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inc Personalized Cell Therapeutic Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Bausch Health Companies Inc
6.2.1 Bausch Health Companies Inc Corporation Information
6.2.2 Bausch Health Companies Inc Description and Business Overview
6.2.3 Bausch Health Companies Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bausch Health Companies Inc Personalized Cell Therapeutic Product Portfolio
6.2.5 Bausch Health Companies Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Personalized Cell Therapeutic Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Corporation Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lupin Personalized Cell Therapeutic Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Sun Pharmaceuticals Industries Ltd
6.6.1 Sun Pharmaceuticals Industries Ltd Corporation Information
6.6.2 Sun Pharmaceuticals Industries Ltd Description and Business Overview
6.6.3 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product Portfolio
6.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
6.7 Hikma Pharmaceuticals PLC
6.6.1 Hikma Pharmaceuticals PLC Corporation Information
6.6.2 Hikma Pharmaceuticals PLC Description and Business Overview
6.6.3 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product Portfolio
6.7.5 Hikma Pharmaceuticals PLC Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Personalized Cell Therapeutic Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 GSK Plc
6.9.1 GSK Plc Corporation Information
6.9.2 GSK Plc Description and Business Overview
6.9.3 GSK Plc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GSK Plc Personalized Cell Therapeutic Product Portfolio
6.9.5 GSK Plc Recent Developments/Updates
6.10 Pfizer Inc
6.10.1 Pfizer Inc Corporation Information
6.10.2 Pfizer Inc Description and Business Overview
6.10.3 Pfizer Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Inc Personalized Cell Therapeutic Product Portfolio
6.10.5 Pfizer Inc Recent Developments/Updates
6.11 Amneal Pharmaceuticals LLC
6.11.1 Amneal Pharmaceuticals LLC Corporation Information
6.11.2 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Description and Business Overview
6.11.3 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product Portfolio
6.11.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.12 Alvogen
6.12.1 Alvogen Corporation Information
6.12.2 Alvogen Personalized Cell Therapeutic Description and Business Overview
6.12.3 Alvogen Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Alvogen Personalized Cell Therapeutic Product Portfolio
6.12.5 Alvogen Recent Developments/Updates
6.13 F. Hoffmann-La Roche Ltd
6.13.1 F. Hoffmann-La Roche Ltd Corporation Information
6.13.2 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Description and Business Overview
6.13.3 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.13.4 F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product Portfolio
6.13.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
6.14 Amgen Inc
6.14.1 Amgen Inc Corporation Information
6.14.2 Amgen Inc Personalized Cell Therapeutic Description and Business Overview
6.14.3 Amgen Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Amgen Inc Personalized Cell Therapeutic Product Portfolio
6.14.5 Amgen Inc Recent Developments/Updates
6.15 Jazz Pharmaceuticals, Inc
6.15.1 Jazz Pharmaceuticals, Inc Corporation Information
6.15.2 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Description and Business Overview
6.15.3 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product Portfolio
6.15.5 Jazz Pharmaceuticals, Inc Recent Developments/Updates
6.16 Amicus Therapeutics, Inc
6.16.1 Amicus Therapeutics, Inc Corporation Information
6.16.2 Amicus Therapeutics, Inc Personalized Cell Therapeutic Description and Business Overview
6.16.3 Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Amicus Therapeutics, Inc Personalized Cell Therapeutic Product Portfolio
6.16.5 Amicus Therapeutics, Inc Recent Developments/Updates
6.17 MeiraGTx Limited
6.17.1 MeiraGTx Limited Corporation Information
6.17.2 MeiraGTx Limited Personalized Cell Therapeutic Description and Business Overview
6.17.3 MeiraGTx Limited Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.17.4 MeiraGTx Limited Personalized Cell Therapeutic Product Portfolio
6.17.5 MeiraGTx Limited Recent Developments/Updates
6.18 Rocket Pharmaceuticals, Inc
6.18.1 Rocket Pharmaceuticals, Inc Corporation Information
6.18.2 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Description and Business Overview
6.18.3 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product Portfolio
6.18.5 Rocket Pharmaceuticals, Inc Recent Developments/Updates
6.19 Gilead Sciences, Inc
6.19.1 Gilead Sciences, Inc Corporation Information
6.19.2 Gilead Sciences, Inc Personalized Cell Therapeutic Description and Business Overview
6.19.3 Gilead Sciences, Inc Personalized Cell Therapeutic Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Gilead Sciences, Inc Personalized Cell Therapeutic Product Portfolio
6.19.5 Gilead Sciences, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Personalized Cell Therapeutic Industry Chain Analysis
7.2 Personalized Cell Therapeutic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Personalized Cell Therapeutic Production Mode & Process
7.4 Personalized Cell Therapeutic Sales and Marketing
7.4.1 Personalized Cell Therapeutic Sales Channels
7.4.2 Personalized Cell Therapeutic Distributors
7.5 Personalized Cell Therapeutic Customers
8 Personalized Cell Therapeutic Market Dynamics
8.1 Personalized Cell Therapeutic Industry Trends
8.2 Personalized Cell Therapeutic Market Drivers
8.3 Personalized Cell Therapeutic Market Challenges
8.4 Personalized Cell Therapeutic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Personalized Cell Therapeutic Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Personalized Cell Therapeutic Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Personalized Cell Therapeutic Market Competitive Situation by Manufacturers in 2022
Table 4. Global Personalized Cell Therapeutic Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Personalized Cell Therapeutic Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Personalized Cell Therapeutic Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Personalized Cell Therapeutic Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Personalized Cell Therapeutic Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Personalized Cell Therapeutic, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Personalized Cell Therapeutic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Personalized Cell Therapeutic, Product Type & Application
Table 12. Global Key Manufacturers of Personalized Cell Therapeutic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Personalized Cell Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cell Therapeutic as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Personalized Cell Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Personalized Cell Therapeutic Sales by Region (2018-2023) & (K Units)
Table 18. Global Personalized Cell Therapeutic Sales Market Share by Region (2018-2023)
Table 19. Global Personalized Cell Therapeutic Sales by Region (2024-2033) & (K Units)
Table 20. Global Personalized Cell Therapeutic Sales Market Share by Region (2024-2033)
Table 21. Global Personalized Cell Therapeutic Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Personalized Cell Therapeutic Revenue Market Share by Region (2018-2023)
Table 23. Global Personalized Cell Therapeutic Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Personalized Cell Therapeutic Revenue Market Share by Region (2024-2033)
Table 25. North America Personalized Cell Therapeutic Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 27. North America Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 28. North America Personalized Cell Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Personalized Cell Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Personalized Cell Therapeutic Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 32. Europe Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 33. Europe Personalized Cell Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Personalized Cell Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Personalized Cell Therapeutic Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Personalized Cell Therapeutic Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Personalized Cell Therapeutic Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Personalized Cell Therapeutic Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Personalized Cell Therapeutic Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Personalized Cell Therapeutic Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Personalized Cell Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Personalized Cell Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Personalized Cell Therapeutic Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Personalized Cell Therapeutic Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Personalized Cell Therapeutic Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Personalized Cell Therapeutic Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Personalized Cell Therapeutic Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Personalized Cell Therapeutic Sales (K Units) by Type (2018-2023)
Table 51. Global Personalized Cell Therapeutic Sales (K Units) by Type (2024-2033)
Table 52. Global Personalized Cell Therapeutic Sales Market Share by Type (2018-2023)
Table 53. Global Personalized Cell Therapeutic Sales Market Share by Type (2024-2033)
Table 54. Global Personalized Cell Therapeutic Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Personalized Cell Therapeutic Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Personalized Cell Therapeutic Revenue Market Share by Type (2018-2023)
Table 57. Global Personalized Cell Therapeutic Revenue Market Share by Type (2024-2033)
Table 58. Global Personalized Cell Therapeutic Price (US$/Unit) by Type (2018-2023)
Table 59. Global Personalized Cell Therapeutic Price (US$/Unit) by Type (2024-2033)
Table 60. Global Personalized Cell Therapeutic Sales (K Units) by Application (2018-2023)
Table 61. Global Personalized Cell Therapeutic Sales (K Units) by Application (2024-2033)
Table 62. Global Personalized Cell Therapeutic Sales Market Share by Application (2018-2023)
Table 63. Global Personalized Cell Therapeutic Sales Market Share by Application (2024-2033)
Table 64. Global Personalized Cell Therapeutic Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Personalized Cell Therapeutic Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Personalized Cell Therapeutic Revenue Market Share by Application (2018-2023)
Table 67. Global Personalized Cell Therapeutic Revenue Market Share by Application (2024-2033)
Table 68. Global Personalized Cell Therapeutic Price (US$/Unit) by Application (2018-2023)
Table 69. Global Personalized Cell Therapeutic Price (US$/Unit) by Application (2024-2033)
Table 70. AbbVie Inc Corporation Information
Table 71. AbbVie Inc Description and Business Overview
Table 72. AbbVie Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Inc Personalized Cell Therapeutic Product
Table 74. AbbVie Inc Recent Developments/Updates
Table 75. Bausch Health Companies Inc Corporation Information
Table 76. Bausch Health Companies Inc Description and Business Overview
Table 77. Bausch Health Companies Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Bausch Health Companies Inc Personalized Cell Therapeutic Product
Table 79. Bausch Health Companies Inc Recent Developments/Updates
Table 80. Teva Pharmaceutical Industries Ltd Corporation Information
Table 81. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 82. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teva Pharmaceutical Industries Ltd Personalized Cell Therapeutic Product
Table 84. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Cipla Personalized Cell Therapeutic Product
Table 89. Cipla Recent Developments/Updates
Table 90. Lupin Corporation Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Lupin Personalized Cell Therapeutic Product
Table 94. Lupin Recent Developments/Updates
Table 95. Sun Pharmaceuticals Industries Ltd Corporation Information
Table 96. Sun Pharmaceuticals Industries Ltd Description and Business Overview
Table 97. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Sun Pharmaceuticals Industries Ltd Personalized Cell Therapeutic Product
Table 99. Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
Table 100. Hikma Pharmaceuticals PLC Corporation Information
Table 101. Hikma Pharmaceuticals PLC Description and Business Overview
Table 102. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Hikma Pharmaceuticals PLC Personalized Cell Therapeutic Product
Table 104. Hikma Pharmaceuticals PLC Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca Personalized Cell Therapeutic Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. GSK Plc Corporation Information
Table 111. GSK Plc Description and Business Overview
Table 112. GSK Plc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. GSK Plc Personalized Cell Therapeutic Product
Table 114. GSK Plc Recent Developments/Updates
Table 115. Pfizer Inc Corporation Information
Table 116. Pfizer Inc Description and Business Overview
Table 117. Pfizer Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pfizer Inc Personalized Cell Therapeutic Product
Table 119. Pfizer Inc Recent Developments/Updates
Table 120. Amneal Pharmaceuticals LLC Corporation Information
Table 121. Amneal Pharmaceuticals LLC Description and Business Overview
Table 122. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Amneal Pharmaceuticals LLC Personalized Cell Therapeutic Product
Table 124. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 125. Alvogen Corporation Information
Table 126. Alvogen Description and Business Overview
Table 127. Alvogen Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Alvogen Personalized Cell Therapeutic Product
Table 129. Alvogen Recent Developments/Updates
Table 130. F. Hoffmann-La Roche Ltd Corporation Information
Table 131. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 132. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. F. Hoffmann-La Roche Ltd Personalized Cell Therapeutic Product
Table 134. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 135. Amgen Inc Corporation Information
Table 136. Amgen Inc Description and Business Overview
Table 137. Amgen Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Amgen Inc Personalized Cell Therapeutic Product
Table 139. Amgen Inc Recent Developments/Updates
Table 140. Jazz Pharmaceuticals, Inc Corporation Information
Table 141. Jazz Pharmaceuticals, Inc Description and Business Overview
Table 142. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Jazz Pharmaceuticals, Inc Personalized Cell Therapeutic Product
Table 144. Jazz Pharmaceuticals, Inc Recent Developments/Updates
Table 145. Amicus Therapeutics, Inc Corporation Information
Table 146. Amicus Therapeutics, Inc Description and Business Overview
Table 147. Amicus Therapeutics, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Amicus Therapeutics, Inc Personalized Cell Therapeutic Product
Table 149. Amicus Therapeutics, Inc Recent Developments/Updates
Table 150. MeiraGTx Limited Corporation Information
Table 151. MeiraGTx Limited Description and Business Overview
Table 152. MeiraGTx Limited Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. MeiraGTx Limited Personalized Cell Therapeutic Product
Table 154. MeiraGTx Limited Recent Developments/Updates
Table 155. Rocket Pharmaceuticals, Inc Corporation Information
Table 156. Rocket Pharmaceuticals, Inc Description and Business Overview
Table 157. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Rocket Pharmaceuticals, Inc Personalized Cell Therapeutic Product
Table 159. Rocket Pharmaceuticals, Inc Recent Developments/Updates
Table 160. Gilead Sciences, Inc Corporation Information
Table 161. Gilead Sciences, Inc Description and Business Overview
Table 162. Gilead Sciences, Inc Personalized Cell Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Gilead Sciences, Inc Personalized Cell Therapeutic Product
Table 164. Gilead Sciences, Inc Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Personalized Cell Therapeutic Distributors List
Table 168. Personalized Cell Therapeutic Customers List
Table 169. Personalized Cell Therapeutic Market Trends
Table 170. Personalized Cell Therapeutic Market Drivers
Table 171. Personalized Cell Therapeutic Market Challenges
Table 172. Personalized Cell Therapeutic Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Personalized Cell Therapeutic
Figure 2. Global Personalized Cell Therapeutic Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Personalized Cell Therapeutic Market Share by Type in 2022 & 2033
Figure 4. Embryonic Stem Cells Product Picture
Figure 5. Adult Stem Cell Product Picture
Figure 6. Induced Pluripotent Cells Product Picture
Figure 7. Other Product Picture
Figure 8. Global Personalized Cell Therapeutic Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Personalized Cell Therapeutic Market Share by Application in 2022 & 2033
Figure 10. Cardiovascular Diseases
Figure 11. Neurological Disorders
Figure 12. Diabetes
Figure 13. Oncology
Figure 14. Other
Figure 15. Global Personalized Cell Therapeutic Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Personalized Cell Therapeutic Market Size (2018-2033) & (US$ Million)
Figure 17. Global Personalized Cell Therapeutic Sales (2018-2033) & (K Units)
Figure 18. Global Personalized Cell Therapeutic Average Price (US$/Unit) & (2018-2033)
Figure 19. Personalized Cell Therapeutic Report Years Considered
Figure 20. Personalized Cell Therapeutic Sales Share by Manufacturers in 2022
Figure 21. Global Personalized Cell Therapeutic Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Personalized Cell Therapeutic Players: Market Share by Revenue in 2022
Figure 23. Personalized Cell Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global Personalized Cell Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 25. North America Personalized Cell Therapeutic Sales Market Share by Country (2018-2033)
Figure 26. North America Personalized Cell Therapeutic Revenue Market Share by Country (2018-2033)
Figure 27. United States Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. Canada Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 29. Europe Personalized Cell Therapeutic Sales Market Share by Country (2018-2033)
Figure 30. Europe Personalized Cell Therapeutic Revenue Market Share by Country (2018-2033)
Figure 31. Germany Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. France Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. U.K. Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Italy Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Russia Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 36. Asia Pacific Personalized Cell Therapeutic Sales Market Share by Region (2018-2033)
Figure 37. Asia Pacific Personalized Cell Therapeutic Revenue Market Share by Region (2018-2033)
Figure 38. China Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. Japan Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. South Korea Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. India Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. Australia Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Taiwan Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 45. Latin America Personalized Cell Therapeutic Sales Market Share by Country (2018-2033)
Figure 46. Latin America Personalized Cell Therapeutic Revenue Market Share by Country (2018-2033)
Figure 47. Mexico Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Brazil Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Argentina Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Personalized Cell Therapeutic Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa Personalized Cell Therapeutic Revenue Market Share by Country (2018-2033)
Figure 52. Turkey Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE Personalized Cell Therapeutic Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of Personalized Cell Therapeutic by Type (2018-2033)
Figure 56. Global Revenue Market Share of Personalized Cell Therapeutic by Type (2018-2033)
Figure 57. Global Personalized Cell Therapeutic Price (US$/Unit) by Type (2018-2033)
Figure 58. Global Sales Market Share of Personalized Cell Therapeutic by Application (2018-2033)
Figure 59. Global Revenue Market Share of Personalized Cell Therapeutic by Application (2018-2033)
Figure 60. Global Personalized Cell Therapeutic Price (US$/Unit) by Application (2018-2033)
Figure 61. Personalized Cell Therapeutic Value Chain
Figure 62. Personalized Cell Therapeutic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed